August 18, 2021
Category :Healthy News
0
Exubera, manufactured by Pfizer, Inc., became the first inhaled insulin to get approval from the United States Food and Drug Administration (US FDA). The FDA approval came late January this year, giving the makers of Exubera license to market the product for the treatment of adults with type I and type 2 diabetes. It has been found in clinical trials that Exubera is as effective as short-acting insulin injections, and that it significantly improves blood sugar control when added to diabetes pills. » Continue Reading
Related terms:
exubera, FDA, insulin
January 27, 2021
Category :Healthy News
0
The concept of Insulin Spray was similar to like the ones asthmatic people use finally became a reality in the 1990’s. Like the inhaler, insulin spray is sprayed by a diabetic patient to take in fine insulin powder into lungs that in turn enters the blood through tiny blood vessels. This makes it more convenient for diabetics to administer insulin without the use of needles. Unfortunately, the nasal insulin spray has not received FDA approval for release because it is still under further study.
» Continue Reading
allergies, Alzheimer, blood vessels, bloodstream, diabetic patient, FDA, insulin, memory
October 13, 2019
Category :Diabetes Facts
0
Question: I’ve been on pioglitazone for 3 years and heard it might be link to bladder cancer. Should I stop taking it?
Last June 15, 2011, The U.S. Food and Drug Administration (FDA) informed the public that use of the diabetes medication Pioglitazone for more than one year may be associated with an increased risk of bladder cancer.
» Continue Reading
Related terms:
bladder, cancer, diabetes, FDA